EFFECTS OF RESVERATROL ON EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS

被引：1

作者：

Heeboll, S. ^{[1
]}

Thomsen, K. L. ^{[1
]}

Clouston, A. ^{[2
]}

Jessen, N. ^{[3
]}

Sundelin, E. I. ^{[3
]}

Pedersen, S. B. ^{[4
]}

Radko, Y. ^{[5
]}

Christensen, L. P. ^{[5
]}

Hebbard, L. ^{[6
,7
]}

Gronbaek, H. ^{[1
]}

George, J. ^{[6
,7
]}

机构：

[1] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, DK-8000 Aarhus, Denmark

[2] Univ Queensland, Ctr Liver Dis Res, Brisbane, Qld, Australia

[3] Res Lab Biochem Pathol, Aarhus, Denmark

[4] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark

[5] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Odense, Denmark

[6] Univ Sydney, Westmead Millennium Inst, Storr Liver Ctr, Sydney, NSW 2006, Australia

[7] Westmead Hosp, Sydney, NSW, Australia

来源：

关键词：

D O I：

10.1016/S0168-8278(15)31175-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0974

引用

页码：S711 / S711

页数：1

共 50 条

[21] Combined alcoholic and non-alcoholic steatohepatitis
Wandji, Line Carolle Ntandja
Gnemmi, Viviane
Mathurin, Philippe
Louvet, Alexandre
JHEP REPORTS, 2020, 2 (03)
[22] Role of Fcgamma receptors in experimental Non-Alcoholic Steatohepatitis
Cabrera, Daniel
Jara, Evelyn
Cruz, Ricardo
Munoz-Durango, Natalia
Rojas de Santiago, Pamela
Kalergis, Alexis
Arrese, Marco
HEPATOLOGY, 2015, 62 : 686A - 686A
[23] Drugs and non-alcoholic steatohepatitis
Farrell, GC
STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 132 - 139
[24] Obesity and non-alcoholic steatohepatitis
García-Monzón, C
STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 117 - 123
[25] Saroglitazar for non-alcoholic steatohepatitis
Baker, Holly
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09): : 698 - 698
[26] Mechanisms of non-alcoholic steatohepatitis
McClain, CJ
Mokshagundam, PL
Barve, SS
Song, ZY
Hill, DB
Chen, T
Deaciuc, I
ALCOHOL, 2004, 34 (01) : 67 - 79
[27] Metformin in non-alcoholic steatohepatitis
Marchesini, G
Brizi, M
Bianchi, G
Tomassetti, S
Zoli, M
Melchionda, N
LANCET, 2001, 358 (9285): : 893 - 894
[28] Selonsertib for non-alcoholic steatohepatitis
Baker, Holly
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 852 - 852
[29] Treatment of non-alcoholic steatohepatitis
Angulo, P
Lindor, KD
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 797 - 810
[30] Fructose and Non-Alcoholic Steatohepatitis
Roeb, Elke
Weiskirchen, Ralf
FRONTIERS IN PHARMACOLOGY, 2021, 12